Karin Hardiman MD, PhD is a surgeon at the Birmingham VA and Professor at University of Alabama at Birmingham. She attended UAB for her MD/PhD degrees. She completed her General Surgery Residency and Colorectal Surgery Fellowship at Oregon Health and Science University. She was an Assistant Professor at the University of Michigan for 8 years where she began her NIH funded lab studying the role of intra-tumor heterogeneity and tumor sub-clones in treatment resistance and metastasis in colorectal cancer. She was recruited to UAB in 2019. In addition to continuing her studies on tumor heterogeneity, she is studying the role of sialylation in treatment resistance and metastasis in colorectal cancer with a focus on using patient tumor samples and organoids. She has mentored many surgical residents and graduate students in translational research. She also holds multiple leadership roles including Associate Director for the UAB Physician Scientist Development Office, co-director of the Future Surgeons and Scientists Investigating Oncology (FUSSION) R25 program, and Assistant Program Director for Resident Research. In addition to her research, she is an active colorectal surgeon and representative for the state of Alabama to the American College of Surgeons, Board of Governors. She was appointed as the Strange Family Endowed Professor in Surgical Sciences Research in February 2024.